Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1974 2
1977 1
1980 1
1982 1
1983 1
1984 1
1985 5
1986 9
1987 6
1988 4
1989 3
1991 5
1992 2
1993 5
1994 11
1995 10
1996 11
1997 27
1998 29
1999 39
2000 44
2001 49
2002 73
2003 90
2004 98
2005 95
2006 95
2007 92
2008 104
2009 109
2010 127
2011 162
2012 133
2013 159
2014 249
2015 333
2016 342
2017 331
2018 382
2019 444
2020 502
2021 504
2022 507
2023 493
2024 197

Text availability

Article attribute

Article type

Publication date

Search Results

5,251 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Bunay-Guisnan
Page 1
Efficacy of Regular Exercise During Pregnancy on the Prevention of Postpartum Depression: The PAMELA Randomized Clinical Trial.
Coll CVN, Domingues MR, Stein A, da Silva BGC, Bassani DG, Hartwig FP, da Silva ICM, da Silveira MF, da Silva SG, Bertoldi AD. Coll CVN, et al. JAMA Netw Open. 2019 Jan 4;2(1):e186861. doi: 10.1001/jamanetworkopen.2018.6861. JAMA Netw Open. 2019. PMID: 30646198 Free PMC article. Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial examines a prespecified secondary outcome of the Physical Activity for Mothers Enrolled in Longitudinal Analysis (PAMELA) Study, a parallel-group, randomized clinical trial. This trial was nested in the 2015 …
DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial examines a prespecified secondary outcome of the Physical Activity for Mot …
Cryo-EM diversifies.
Lea SM, Williams PA. Lea SM, et al. Curr Opin Struct Biol. 2022 Dec;77:102469. doi: 10.1016/j.sbi.2022.102469. Epub 2022 Sep 29. Curr Opin Struct Biol. 2022. PMID: 36183448 No abstract available.
Rhomboid Flap.
Hon HH, Chandra SR. Hon HH, et al. Atlas Oral Maxillofac Surg Clin North Am. 2020 Mar;28(1):17-22. doi: 10.1016/j.cxom.2019.11.005. Epub 2020 Jan 2. Atlas Oral Maxillofac Surg Clin North Am. 2020. PMID: 32008705 Review. No abstract available.
Letter to editors-in-chief.
Massoudi P, Wickberg B. Massoudi P, et al. J Affect Disord. 2023 May 15;329:9-10. doi: 10.1016/j.jad.2023.02.107. Epub 2023 Feb 24. J Affect Disord. 2023. PMID: 36841296 No abstract available.
Pamela Klein (she/her).
[No authors listed] [No authors listed] Cell Rep Med. 2022 Mar 15;3(3):100566. doi: 10.1016/j.xcrm.2022.100566. Epub 2022 Mar 15. Cell Rep Med. 2022. PMID: 35584658 Free PMC article.
Pamela Klein, Nurse Manager of Transgender Services at Boston Health Care for the Homeless Program (BHCHP) and Nurse Liaison for Boston Medical Center (BMC)'s Center for Transgender Medicine and Surgery (CTMS), shares how the COVID-19 pandemic has affected her practice and
Pamela Klein, Nurse Manager of Transgender Services at Boston Health Care for the Homeless Program (BHCHP) and Nurse Liaison for Bost
Pamela Sklar.
Charney AW. Charney AW. Neuropsychopharmacology. 2018 Apr;43(5):1191-1192. doi: 10.1038/npp.2018.1. Neuropsychopharmacology. 2018. PMID: 29535460 Free PMC article. No abstract available.
Nurse Serenity Lounges.
Pamela S.. Pamela S.. Am J Nurs. 2022 Sep 1;122(9):11. doi: 10.1097/01.NAJ.0000874028.37943.12. Am J Nurs. 2022. PMID: 36005772 No abstract available.
Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Correlative Analysis of the CALGB 40601 and PAMELA Trials.
Fernandez-Martinez A, Pascual T, Singh B, Nuciforo P, Rashid NU, Ballman KV, Campbell JD, Hoadley KA, Spears PA, Pare L, Brasó-Maristany F, Chic N, Krop I, Partridge A, Cortés J, Llombart-Cussac A, Prat A, Perou CM, Carey LA. Fernandez-Martinez A, et al. JAMA Oncol. 2023 Apr 1;9(4):490-499. doi: 10.1001/jamaoncol.2022.6288. JAMA Oncol. 2023. PMID: 36602784 Free PMC article. Clinical Trial.
The primary end point was pCR, with a secondary end point of EFS. In the PAMELA trial, 151 patients received neoadjuvant treatment with trastuzumab and lapatinib for 18 weeks. ...MAIN OUTCOMES AND MEASURES: Immune-related gene expression profiling by RNA sequencing and TIL …
The primary end point was pCR, with a secondary end point of EFS. In the PAMELA trial, 151 patients received neoadjuvant treatment wi …
Pamela Mitchell, BSN, PhD, FAHA, FAAN-WSNA.
Ali P, McDonald T. Ali P, et al. Int Nurs Rev. 2023 Sep;70(3):258-259. doi: 10.1111/inr.12865. Epub 2023 Jul 24. Int Nurs Rev. 2023. PMID: 37486866 No abstract available.
5,251 results